Legend Biotech Corporation
LEGN
$35.64
-$0.27-0.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -483.94% | 120.97% | -588.73% | 69.57% | 58.71% |
| Total Depreciation and Amortization | -21.11% | 27.76% | 3.10% | -12.57% | 16.85% |
| Total Amortization of Deferred Charges | -- | -34.39% | -14.21% | -- | -- |
| Total Other Non-Cash Items | 286.85% | -157.12% | 32,597.88% | 99.23% | -145.25% |
| Change in Net Operating Assets | 8.10% | -360.37% | -253.05% | -87.92% | 1,019.58% |
| Cash from Operations | -26.41% | -8.25% | -4,492.49% | -110.64% | 116.22% |
| Capital Expenditure | 15.81% | -15.16% | 39.57% | 45.28% | -43.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 402.63% | -125.81% | 147.84% | -77.53% | -194.67% |
| Cash from Investing | 392.16% | -126.69% | 147.31% | -75.60% | -197.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 16.99% | 19.59% | -0.34% | -53.03% | -349.34% |
| Issuance of Common Stock | 139.47% | -88.85% | 155.74% | 33.10% | 155.88% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 300.30% | -107.84% | 344.50% | 14.92% | -10.16% |
| Foreign Exchange rate Adjustments | 161.54% | -534.16% | 5,722.22% | 102.62% | -123.59% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 189.81% | -166.87% | 137.06% | -83.17% | -220.97% |